gvs 111 has been researched along with mecamylamine in 1 studies
Studies (gvs 111) | Trials (gvs 111) | Recent Studies (post-2010) (gvs 111) | Studies (mecamylamine) | Trials (mecamylamine) | Recent Studies (post-2010) (mecamylamine) |
---|---|---|---|---|---|
91 | 2 | 31 | 1,997 | 68 | 376 |
Protein | Taxonomy | gvs 111 (IC50) | mecamylamine (IC50) |
---|---|---|---|
Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | 0.44 | |
Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | 2.0833 | |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | 1.6133 | |
Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | 1.8 | |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | 0.6 | |
Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens (human) | 3.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belnik, AP; Ostrovskaya, RU; Radionova, KS | 1 |
1 other study(ies) available for gvs 111 and mecamylamine
Article | Year |
---|---|
Original nootropic drug noopept prevents memory deficit in rats with muscarinic and nicotinic receptor blockade.
Topics: Animals; Cholinergic Agonists; Cholinergic Antagonists; Dipeptides; Male; Mecamylamine; Memory; Memory Disorders; Nicotinic Antagonists; Nootropic Agents; Rats; Scopolamine | 2008 |